/Companies

Assembly Biosciences

2 known investors

Find your way into Assembly Biosciences

Sign up to see every warm intro you have to Assembly Biosciences

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Assembly Biosciences team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Assembly Bio is a biopharmaceutical company developing novel therapeutic candidates for viral and liver diseases, including programs targeting herpesviruses, hepatitis delta virus, hepatitis B virus, and cholestatic liver diseases.

Founders & leadership

JOJason Okazaki
Jason OkazakiChief Executive Officer & PresidentChief Executive Officer & President at Assemblybio
WD
William Delaney, PhDChief Scientific Officer
AG
Anuj Gaggar, MD, PhDChief Medical Officer

Investors · 2

Founder mafia

2 people who came through Assembly Biosciences went on to found or lead other companies.

Frequently asked questions

What does Assembly Biosciences do?
Assembly Bio is a biopharmaceutical company developing novel therapeutic candidates for viral and liver diseases, including programs targeting herpesviruses, hepatitis delta virus, hepatitis B virus, and cholestatic liver diseases.
Who are Assembly Biosciences's investors?
Assembly Biosciences's investors include Avoro Capital Advisors, Longitude Capital.